Davis's Drug Guide
mirdametinib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
mir-da-me-ti-nib
Trade Name(s)
- Gomekli
Ther. Class.
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Mirdametinib." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580218/all/mirdametinib.
Vallerand AHA, Sanoski CAC. Mirdametinib. Davis's Drug Guide. F.A. Davis Company; 2026. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580218/all/mirdametinib. Accessed November 15, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Mirdametinib. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580218/all/mirdametinib
Vallerand AHA, Sanoski CAC. Mirdametinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 November 15]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580218/all/mirdametinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - mirdametinib
ID - 3580218
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580218/all/mirdametinib
PB - F.A. Davis Company
ET - 20
DB - Emergency Central
DP - Unbound Medicine
ER -
